Today's Daily Dose brings you news about the update on Evoke Pharma's resubmitted New Drug Application for Gimoti; FDA's Fast Track Designation for Genprex' investigational immunogene therapy Oncoprex and Horizon Therapeutics securing FDA approval of TEPEZZA for the treatment of Thyroid Eye Disease, among others.
from RTT - Biotech https://ift.tt/37jkIm6
via IFTTT
No comments:
Post a Comment